The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124944362 12494436 2 F 201605 20160629 20160623 20160707 EXP US-JAZZ-2016-US-011224 JAZZ 48.35 YR M Y 0.00000 20160707 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124944362 12494436 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID Y 21196 2.25 G ORAL SOLUTION
124944362 12494436 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS Y 21196 ORAL SOLUTION
124944362 12494436 3 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID Y 21196 4.5 G ORAL SOLUTION
124944362 12494436 4 SS XYREM SODIUM OXYBATE 1 Oral 3.75 G, BID Y 21196 3.75 G ORAL SOLUTION
124944362 12494436 5 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 UNK U 0 TABLET
124944362 12494436 6 C ADDERALL XR AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 UNK U 0 CAPSULE
124944362 12494436 7 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 UNK U 0 TABLET
124944362 12494436 8 C Aspire 2 UNK U 0 TABLET
124944362 12494436 9 C LANTUS INSULIN GLARGINE 1 UNK U 0
124944362 12494436 10 C Multivitamin and mineral 2 UNK U 0 TABLET
124944362 12494436 11 C NOVOLOG INSULIN ASPART 1 UNK U 0
124944362 12494436 12 C PRAVASTATIN SODIUM. PRAVASTATIN SODIUM 1 UNK U 0 TABLET
124944362 12494436 13 C FLONASE FLUTICASONE PROPIONATE 1 U 0 SPRAY

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124944362 12494436 1 Narcolepsy
124944362 12494436 5 Product used for unknown indication
124944362 12494436 6 Product used for unknown indication
124944362 12494436 7 Product used for unknown indication
124944362 12494436 8 Product used for unknown indication
124944362 12494436 9 Product used for unknown indication
124944362 12494436 10 Product used for unknown indication
124944362 12494436 11 Product used for unknown indication
124944362 12494436 12 Product used for unknown indication
124944362 12494436 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
124944362 12494436 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124944362 12494436 Anxiety
124944362 12494436 Balance disorder
124944362 12494436 Condition aggravated
124944362 12494436 Feeling drunk
124944362 12494436 Poor quality sleep
124944362 12494436 Somnolence
124944362 12494436 Type 1 diabetes mellitus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124944362 12494436 1 201604 201605 0
124944362 12494436 2 201605 201605 0
124944362 12494436 3 201605 20160522 0
124944362 12494436 4 20160523 0
124944362 12494436 5 20150403 201606 0
124944362 12494436 6 20150302 0
124944362 12494436 7 20140822 0
124944362 12494436 8 20130222 0
124944362 12494436 9 20130222 0
124944362 12494436 10 20130222 0
124944362 12494436 11 20130222 0
124944362 12494436 12 20130222 0